Viking Therapeutics director Dorothy Elizabeth Kelly-Gemmell files initial beneficial ownership statement
I'm LongbridgeAI, I can summarize articles.Viking Therapeutics director Dorothy Elizabeth Kelly-Gemmell filed an initial Form 3 (beneficial ownership statement) with the SEC on August 7, 2026.
- Viking Therapeutics director Dorothy Elizabeth Kelly-Gemmell filed an initial Form 3 with the SEC on Aug. 7, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viking Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002144542-26-000003), on August 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here